In 2020, Saxenda was approved for children and adolescents 12 years and older with obesity or overweight with an associated health problem, such as high blood pressure
According to research, its possible to lose around 2% of your initial body weight in four weeks
This biological appetite adjustment is why the appetite suppression often feels natural rather than like forced restraint
The central theory behind AOD-9604s action revolves around its ability to enhance the breakdown of fats (lipolysis) while reducing the formation of new fat (lipogenesis)
GLP-1 drugs, including semaglutide and tirzepatide, are among the most successful treatments weve ever seen
Heres what actually matters: The critical distinction: Retatrutide isnt just a little better. The most recent Phase 3 data (TRIUMPH-4 trial, December 2025) showed participants on the 12 mg dose lost an average of 28.7% of their body weight at 68 weeks